Edit
Atrandi Biosciences | Droplet Genomics
https://www.atrandi.com/Last activity: 19.02.2025
Probably Closed
Atrandi Biosciences is breaking new ground in high-throughput analysis technologies. Providing simple-to-adopt and easy-to-use droplet microfluidics and high-throughput screening (HTS) workflows. Droplet microfluidics technology is at the core of our products and provides an unmatched platform for exploring the complexity of biology in a high-throughput manner. Droplet microfluidics enables compartmentalizing molecular biology reactions into millions of pico-liter droplets, empowering you to study biological samples at the resolution of single cells and single molecules. Our work is at the intersection of life sciences, engineering, and machine learning. We deliver elegant solutions and novel tools for groundbreaking high-throughput research by integrating different technologies.
Location: Lithuania, Vilnius County, Vilnius
Employees: 51-200
Total raised: $29.9M
Founded date: 2016
Investors 2
| Date | Name | Website |
| 20.04.2023 | Vsquared V... | vsquared.v... |
| 06.11.2023 | Metaplanet... | metaplanet... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 19.02.2025 | Series A | $25M | - |
| 29.03.2023 | Series A | $4.9M | Vsquared V... |
Mentions in press and media 4
| Date | Title | Description |
| 19.02.2025 | Atrandi Biosciences Raises $25M in Series A Funding | Atrandi Biosciences, a Vilnius, Lithuania-based life sciences company advancing new single-cell analysis technology, raised $25M in Series A funding. The round was led by Lux Capital, with participation from Vsquared Ventures, Practica Capi... |
| 29.03.2023 | Lithuanian biotech Atrandi Biosciences raises €4.5M in Series A funding | Lithuanian biotech Atrandi Biosciences raises €4.5M in Series A funding 29 March, 2023, 12:37 Rostyslav Sobachynskyi --> --> --> -->--> --> --> --> --> --> --> --> --> Vilnius-based emerging biotech... |
| 28.03.2023 | Atrandi Biosciences Secures $4.8M in Funding | Atrandi Biosciences, a Vilnius, Lithuania and Denver, CO-based provider of microfluidic solutions for the life sciences, raised $4.8M in funding. The round, which brought total funding to over $8M, was led by Vsquared Ventures, Practica Cap... |
| - | Atrandi Biosciences | “Atrandi Biosciences” |